These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 12220106
1. Histopathology of lupus-like nephritis in Dnase1-deficient mice in comparison to NZB/W F1 mice. Jacob M, Napirei M, Ricken A, Dixkens C, Mannherz HG. Lupus; 2002; 11(8):514-27. PubMed ID: 12220106 [Abstract] [Full Text] [Related]
2. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Rudofsky UH, Evans BD, Balaban SL, Mottironi VD, Gabrielsen AE. Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150 [Abstract] [Full Text] [Related]
3. Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice. Lui SL, Yung S, Tsang R, Zhang F, Chan KW, Tam S, Chan TM. Lupus; 2008 Apr; 17(4):305-13. PubMed ID: 18413412 [Abstract] [Full Text] [Related]
4. Genetic control of glycoprotein 70 autoantigen production and its influence on immune complex levels and nephritis in murine lupus. Tucker RM, Vyse TJ, Rozzo S, Roark CL, Izui S, Kotzin BL. J Immunol; 2000 Aug 01; 165(3):1665-72. PubMed ID: 10903778 [Abstract] [Full Text] [Related]
5. Features of systemic lupus erythematosus in Dnase1-deficient mice. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Möröy T. Nat Genet; 2000 Jun 01; 25(2):177-81. PubMed ID: 10835632 [Abstract] [Full Text] [Related]
6. Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis. Zykova SN, Tveita AA, Rekvig OP. PLoS One; 2010 Aug 10; 5(8):. PubMed ID: 20856893 [Abstract] [Full Text] [Related]
7. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice. Sitrin J, Suto E, Wuster A, Eastham-Anderson J, Kim JM, Austin CD, Lee WP, Behrens TW. J Immunol; 2017 Aug 15; 199(4):1238-1249. PubMed ID: 28696253 [Abstract] [Full Text] [Related]
8. Glomerular immune deposits in murine lupus models may contain histones. Schmiedeke T, Stoeckl F, Muller S, Sugisaki Y, Batsford S, Woitas R, Vogt A. Clin Exp Immunol; 1992 Dec 15; 90(3):453-8. PubMed ID: 1458682 [Abstract] [Full Text] [Related]
9. New immunosuppresor strategies in the treatment of murine lupus nephritis. Alperovich G, Rama I, Lloberas N, Franquesa M, Poveda R, Gomà M, Herrero-Fresneda I, Cruzado JM, Bolaños N, Carrera M, Grinyó JM, Torras J. Lupus; 2007 Dec 15; 16(1):18-24. PubMed ID: 17283580 [Abstract] [Full Text] [Related]
10. FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. Bergtold A, Gavhane A, D'Agati V, Madaio M, Clynes R. J Immunol; 2006 Nov 15; 177(10):7287-95. PubMed ID: 17082647 [Abstract] [Full Text] [Related]
11. The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis. Koh AE, Njoroge SW, Feliu M, Cook A, Selig MK, Latchman YE, Sharpe AH, Colvin RB, Paul E. J Autoimmun; 2011 Aug 15; 37(1):48-57. PubMed ID: 21561736 [Abstract] [Full Text] [Related]
12. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. Drake CG, Rozzo SJ, Hirschfeld HF, Smarnworawong NP, Palmer E, Kotzin BL. J Immunol; 1995 Mar 01; 154(5):2441-7. PubMed ID: 7868910 [Abstract] [Full Text] [Related]
13. Nuclease deficiencies promote end-stage lupus nephritis but not nephritogenic autoimmunity in (NZB × NZW) F1 mice. Fismen S, Mortensen ES, Rekvig OP. Immunol Cell Biol; 2011 Jan 01; 89(1):90-9. PubMed ID: 20548325 [Abstract] [Full Text] [Related]
14. A novel susceptibility locus on chromosome 2 in the (New Zealand Black x New Zealand White)F1 hybrid mouse model of systemic lupus erythematosus. Rahman ZS, Tin SK, Buenaventura PN, Ho CH, Yap EP, Yong RY, Koh DR. J Immunol; 2002 Mar 15; 168(6):3042-9. PubMed ID: 11884477 [Abstract] [Full Text] [Related]
15. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus. Decker DA, Grant C, Oh L, Becker PM, Young D, Jordan S. Lupus; 2014 Jul 15; 23(8):802-12. PubMed ID: 24759631 [Abstract] [Full Text] [Related]
16. Lupus nephritis progression in FcγRIIB-/-yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease. Horvei KD, Pedersen HL, Fismen S, Thiyagarajan D, Schneider A, Rekvig OP, Winkler TH, Seredkina N. PLoS One; 2017 Jul 15; 12(11):e0188863. PubMed ID: 29190833 [Abstract] [Full Text] [Related]
17. Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis. Fismen S, Hedberg A, Fenton KA, Jacobsen S, Krarup E, Kamper AL, Rekvig OP, Mortensen ES. Lupus; 2009 Jun 15; 18(7):597-607. PubMed ID: 19433459 [Abstract] [Full Text] [Related]
18. Function of the Th17/interleukin-17A immune response in murine lupus nephritis. Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB, Koyro T, Peters A, Velden J, Hünemörder S, Haag F, Steinmetz OM, Mittrücker HW, Stahl RA, Panzer U. Arthritis Rheumatol; 2015 Feb 15; 67(2):475-87. PubMed ID: 25385550 [Abstract] [Full Text] [Related]
19. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T. Ann Rheum Dis; 2008 Feb 15; 67(2):154-61. PubMed ID: 17557887 [Abstract] [Full Text] [Related]
20. Autoimmune alterations induced by the New Zealand Black Lbw2 locus in BWF1 mice. Haraldsson MK, dela Paz NG, Kuan JG, Gilkeson GS, Theofilopoulos AN, Kono DH. J Immunol; 2005 Apr 15; 174(8):5065-73. PubMed ID: 15814738 [Abstract] [Full Text] [Related] Page: [Next] [New Search]